Detalhe da pesquisa
1.
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment.
J Am Acad Dermatol
; 78(6): 1149-1155.e1, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29080806
2.
The maraviroc expanded access program - safety and efficacy data from an open-label study.
HIV Clin Trials
; 16(1): 10-21, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25777185
3.
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents.
HIV Clin Trials
; 16(2): 72-80, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25923596
4.
Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.
HIV Clin Trials
; 13(2): 83-9, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22510355
5.
Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents.
HIV Clin Trials
; 16(6): 236-7, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26777796
6.
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial.
Clin Infect Dis
; 43(10): 1337-46, 2006 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17051503
7.
Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment.
AIDS
; 30(8): 1229-38, 2016 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26854810
8.
Treatment of Scedosporium apiospermum brain abscesses with posaconazole.
Clin Infect Dis
; 34(12): 1648-50, 2002 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12032903
9.
Five-year safety evaluation of maraviroc in HIV-1-infected treatment-experienced patients.
J Acquir Immune Defic Syndr
; 65(1): 78-81, 2014 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24419064
10.
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
AIDS
; 28(5): 717-25, 2014 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-24983542
11.
Single-dose pharmacokinetics, safety, and tolerability of modified-release formulations of lersivirine in healthy subjects.
Clin Pharmacol Drug Dev
; 3(6): 472-6, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27129121
12.
Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers.
Antimicrob Agents Chemother
; 49(12): 4903-10, 2005 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16304151